Shing-Hu Cheung相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

Discovery and Characterization of the Potent and Highly Selective 1,7-Naphthyridine-Based Inhibitors BAY-091 and BAY-297 of the Kinase PIP4K2A

发现并表征强效且高选择性的 1,7-萘啶类激酶 PIP4K2A 抑制剂 BAY-091 和 BAY-297

期刊:Journal of Medicinal Chemistry

影响因子:6.8

doi:10.1021/acs.jmedchem.1c01245

Lars Wortmann, Nico Bräuer, Simon J Holton, Horst Irlbacher, Jörg Weiske, Christian Lechner, Robin Meier, Jakob Karén, Catrine Berthold Siöberg, Vera Pütter, Clara D Christ, Antonius Ter Laak, Philip Lienau, Ralf Lesche, Barbara Nicke, Shing-Hu Cheung, Marcus Bauser, Andrea Haegebarth, Franz von Nus

发表日期：2021

文献求助收藏

RAF dimer inhibition enhances the antitumor activity of MEK inhibitors in K-RAS mutant tumors

RAF 二聚体抑制可增强 MEK 抑制剂在 K-RAS 突变肿瘤中的抗肿瘤活性

期刊:Molecular Oncology

doi:10.1002/1878-0261.12698

Xi Yuan, Zhiyu Tang, Rong Du, Zhan Yao, Shing-Hu Cheung, Xinwen Zhang, Jing Wei, Yuan Zhao, Yunguang Du, Ye Liu, Xiaoxia Hu, Wenfeng Gong, Yong Liu, Yajuan Gao, Zhiyue Huang, Zongfu Cao, Min Wei, Changyou Zhou, Lai Wang, Neal Rosen, Paul D Smith, Lusong Luo

发表日期：2020

文献求助收藏

ADTRP regulates TFPI expression via transcription factor POU1F1 involved in coronary artery disease

ADTRP 通过转录因子 POU1F1 调节与冠状动脉疾病有关的 TFPI 表达

影响因子:2.6

doi:10.1016/j.gene.2020.144805

Chunyan Luo, Elisabeth Pook, Fan Wang, Stephen R Archacki, Bo Tang, Weiyi Zhang, Jing-Shan Hu, Jian Yang, Kirsten Leineweber, Martin Bechem, Weifeng Huang, Yinhong Song, Shing-Hu Cheung, Volker Laux, Tie Ke, Xiang Ren, Xin Tu, Qiuyun Chen, Qing Kenneth Wang, Chengqi Xu

发表日期：2020

文献求助收藏

Androgen inhibits key atherosclerotic processes by directly activating ADTRP transcription

雄激素通过直接激活 ADTRP 转录来抑制关键动脉粥样硬化过程

期刊:Biochimica et Biophysica Acta-Molecular Basis of Disease

影响因子:4.2

doi:10.1016/j.bbadis.2017.06.015

Chunyan Luo, Elisabeth Pook, Bo Tang, Weiyi Zhang, Sisi Li, Kirsten Leineweber, Shing-Hu Cheung, Qiuyun Chen, Martin Bechem, Jing-Shan Hu, Volker Laux, Qing Kenneth Wang

动脉粥样硬化

发表日期：2017

文献求助收藏

BGB-283, a Novel RAF Kinase and EGFR Inhibitor, Displays Potent Antitumor Activity in BRAF-Mutated Colorectal Cancers

BGB-283 是一种新型 RAF 激酶和 EGFR 抑制剂，在 BRAF 突变的结肠直肠癌中表现出强大的抗肿瘤活性

期刊:Molecular Cancer Therapeutics

影响因子:5.3

doi:10.1158/1535-7163.MCT-15-0262

Zhiyu Tang, Xi Yuan, Rong Du, Shing-Hu Cheung, Guoliang Zhang, Jing Wei, Yuan Zhao, Yingcai Feng, Hao Peng, Yi Zhang, Yunguang Du, Xiaoxia Hu, Wenfeng Gong, Yong Liu, Yajuan Gao, Ye Liu, Rui Hao, Shengjian Li, Shaohui Wang, Jiafu Ji, Lianhai Zhang, Shuangxi Li, David Sutton, Min Wei, Changyou Zhou,

发表日期：2015

文献求助收藏